ssti-logo

Higher education R&D expenditures (HERD) grew by 38.9 percent from 2008 to 2017, an increase of more than $21 billion, according to an SSTI analysis of recently released data from the National Science Foundation’s National Center for Science and Engineering Statistics. From 2016 to 2017, HERD grew by $3.8 billion, the largest year-over-year increase since 2010-2011. Higher education R&D expenditures grew the fastest in Connecticut (66.2 percent), Massachusetts (63.9 percent), and Wyoming (63.0 percent) over the 10-year period, while New York ($2.3 billion increase), California ($2.0 billion), and Massachusetts ($1.6 billion) saw the largest absolute gains during this time.

childrens-national-ground-breaking-2018-judy-linkedin

Congratulations to team at #ChildrensNational re groundbreaking for new research & #ChildrensInnovation center on former #WalterReed campus. $150M invested near term creating 300 construction and 110 permanent jobs. Honoring campus' legacy while advancing pediatric treatment, diagostics, and prevention for patients in DC and around the globe. Campus will include not only Children's R&D but also clinical services, schools, retail, affordable housing and more! "Live, work, thrive!"

sbir-seed-fund-logo

The National Science Foundation's Small Business Innovation Research (SBIR) program- also known as America's Seed Fund powered by NSF - provides small businesses with equity-free funding to conduct research and development (R&D) work that will lead to the commercialization of innovative new products and services. The NSF SBIR program seeks innovative proposals that show promise of commercial and societal impact. We invite the submission of proposals in almost any area of science and technology (more information on our technical topics is available here).

pharma-drugs-pixa

Unlike their biotech counterparts, pharmaceutical companies have largely surpassed analyst expectations on earnings per share during the third quarter. Yet, pharma stocks have not been immune to the stock market swoon of recent weeks.

startup-revolution-logo

America’s long-held singular dominance of startup and venture capital activity is being challenged by the rapid ascent of cities in Asia, Europe, and elsewhere. While the United States remains the clear global leader, the rest of the world is gaining ground at an accelerating rate.

maryland-department-of-commerce-logo.png

Driven by breakthrough research and innovation, biohealth and life science are high-risk, high-expense fields. The right location is critical to your success, but that doesn’t mean you need to pay Boston’s and San Francisco’s high rents for lab and office space. Maryland, a booming bio hub itself, is not only cost-efficient, but offers many advantages you may not find elsewhere. Before narrowing your shortlist for your new biotech business or expansion of existing biotech business, consider these six factors that contribute to Maryland’s innovation ecosystem.

regenxbio-rocket-pharma-logo

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, and Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), a leading U.S.-based multi-platform gene therapy company, today announced an exclusive, worldwide license agreement for Rocket to develop and commercialize gene therapy treatments for Danon disease using REGENXBIO's NAV AAV9 vector, as well as exclusive options for two additional NAV AAV vectors for the treatment of Danon disease.

bhi-launch-tedco-moco-logos.png

Thursday, December 13, 2018

  • Business formation and governance
  • Advisory board vs board of directors
  • Equity incentive plans
  • Non-disclosure agreements (with potential co-owners/joint ventures/investors and employees)
  • Worker classifications (exempt vs non-exempt; W2 or 1099)
  • Employment contracts
  • Lease or distributor agreements
  • Customer agreements (for Beta testing and beyond)
  • CRADA’s and technology transfer agreements

Learn about these topics and more through the December 13th PathFinder Innovation Program. (There is no charge to attend in person or by videoconference. However, pre-registration by NOON, 12/12 is required).

  • 1:00-1:30 p.m. Networking Lunch
  • 1:30-2:45 p.m.– Issues Overview (in person/by videoconference) 
    • Speakers:
      • Anthony Millin, Esq. – Startups Chair, Shulman Rogers
      • Lynn Perry Parker, Esq. – Principal, LPP Law
  • 2:45 p.m. – 1:1 Office Hours (in person/by videoconference)*


This program is cosponsored by BioHealth Innovation, Launch Workplaces, TEDCO and Montgomery County. It is open to anyone in the BioHealth Capital Region.  

To register/For more information, email:  BHI@BioHealthInnovation.  *Participation in Overview Discussion  (in person/by videoconference) is required to attend 1:1  office hours.

Location Rockville, MD

university-system-of-maryland-usm-2-logo

The University System of Maryland (USM) is Maryland's public higher education system, consisting of 11 degree-granting universities, two regional higher education centers and one environmental research institution.  With approximately 170,000 students and 38,000 graduates each year, USM is the most significant producer of talented workers and educated citizens in Maryland.  USM institutions, faculty, students and graduates attract billions of federal and privately funded research dollars to the state that support thousands of jobs.  They also create hundreds of new companies.  Combined, these activities enable USM to support one of America’s most vibrant economies.